MARK SILVERMAN: Open Payments
NPI 1972620854 · BIRMINGHAM, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173 in 7 payments from 3 companies in 2025. Trend: 2023 $60 · 2024 $49 · 2025 $173
Food & beverage: $173
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 5 | $131 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| LivaNova USA, Inc. | 1 | $19 |
Products named: TYSABRI, ULTOMIRIS, VNS Therapy.
Industry payments across MI — which companies pay providers there.
